Objective: To analyze the prevalence of CALR and JAK2 mutation co-occurrence in myelofibrosis (MF) patients in KP. Methods: This cross-sectional study included Myelofibrosis (MF) patients (n = 50) enrolled in the Hematology/Oncology department of Hayatabad Medical Complex (HMC), Institute of Radiotherapy and Nuclear Medicine, Peshawar (IRNUM) and Blood Diseases Clinic, Peshawar. Non-probability convenience sampling technique was used. All patients with JAK2 V617F positive and negative primary or secondary MF were included. After taking blood samples, DNA was extracted manually and analyzed for JAK2 mutations using conventional PCR. Sanger sequencing technique was employed to analyze the samples for CALR mutations. Data were recorded & analyzed statistically.
Results: Among the 50 patients, 48(96%) had JAK2 mutations. The typical CALR mutations was not identified in the current study. However, two specific genetic variants were identified in 30 patients i.e., a single nucleotide polymorphism (c.1381 G > T) in the 3' UTR and a novel insertion-deletion variant (c. 1099 CTT > AC). Seven patients had the Indel frameshift variant (p.Leu 367 Thr Fx 63), whereas 23 had SNP. In JAK-2 positive patients (n=28), six had the Indel variant, and 22 had the SNP. Two patients were JAK2 negative, one with SNP and the other with a frameshift mutation.
Conclusion: Majority of the MF patients had a novel frameshift variant (p. Leu367Thr Fx63) (n = 07) and an SNP in the 3' UTR (G > T) (n = 23) in CALR gene.